IL1B and neoplasm: We show that TREM1 myeloid-derived cytokines IL1 and OSM activate the inflammatory NF-κB family of transcription factors within the BIT tumor epithelium and lower the sensitivity of human BCC explant tumors to SMOi treatment, conferring resistance.